Emfizatamab Monoclonal Antibody
Emfizatamabis a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
UniProt
Q07011, P15391, P07766, Q9NZQ7
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
(scFv-kappa-heavy) -G1_L-kappa- (scFv-heavy-kappa) - (scFv-heavy-kappa)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TGF-beta (1D11.16.8), CF640R conjugate, 0.1mg/mL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
